Clinical Trial Update: Multiple Dose Study Of BIIB118 (PF-05251749) In Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 multiple-dose study of BIIB118 (PF-05251749) in healthy volunteers completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Healthy Subjects

Drugs mentioned

• BIIB118 (PF-05251749)

Snippet

Sponsor: Biogen | Conditions: Healthy Adult Subjects, Healthy Elderly Subjects | Phase 1 | Status: COMPLETED | Results posted: 2018-10-15